ITCC-083 Ponatinib

  • Innovative Therapies
    for Children with Cancer in Europe
  • Contact us

ITCC-083 Ponatinib

An Open-Label, Single-Arm, Phase 1/2 Study Evaluating the Safety and Efficacy of Single- Agent Ponatinib for the Treatment of advanced Leukemias or Solid Tumors in Pediatric Participants

Promotor Name : Incyte

Investigator Name : M. ZWAAN

Trial registered on : NCT03934372